ESTRO Multidisciplinary Management of Breast Cancer 2017

Majority of PMRT was loco-reg RT incl IMN 98% of PMRT planning was without compromises due to the reconstruction

384 patients 95% stage II-III breast cancer Median FU 5.6 yr (range 1.3-13.4) 5 yr locoreg control 99.0%

5 yr DFS 86.1% 5 yr OS 92.4%